Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1986 1
1987 1
1988 2
1989 2
1994 1
1995 1
1997 1
1998 2
1999 2
2000 5
2001 1
2002 6
2003 9
2004 6
2005 5
2006 11
2007 11
2008 13
2009 8
2010 16
2011 20
2012 17
2013 13
2014 16
2015 20
2016 19
2017 22
2018 19
2019 33
2020 20
2021 28
2022 11
Text availability
Article attribute
Article type
Publication date

Search Results

307 results
Results by year
Filters applied: . Clear all
Page 1
Type 2 diabetes mellitus increases the risk of hepatocellular carcinoma in subjects with chronic hepatitis B virus infection: a meta-analysis and systematic review.
Tan Y, Wei S, Zhang W, Yang J, Yang J, Yan L. Tan Y, et al. Cancer Manag Res. 2019 Jan 14;11:705-713. doi: 10.2147/CMAR.S188238. eCollection 2019. Cancer Manag Res. 2019. PMID: 30679924 Free PMC article. Review.
BACKGROUND: Type 2 diabetes mellitus has been proved to be a risk factor of hepatocellular carcinoma, but how diabetes affects incidence of hepatocellular carcinoma among patients with chronic hepatitis B virus infection remains co …
BACKGROUND: Type 2 diabetes mellitus has been proved to be a risk factor of hepatocellular carcinoma, but how …
COVID-19 vaccination in patients with diabetes mellitus: Current concepts, uncertainties and challenges.
Pal R, Bhadada SK, Misra A. Pal R, et al. Diabetes Metab Syndr. 2021 Mar-Apr;15(2):505-508. doi: 10.1016/j.dsx.2021.02.026. Epub 2021 Feb 25. Diabetes Metab Syndr. 2021. PMID: 33662837 Free PMC article. Review.
BACKGROUND AND AIMS: To summarize the available evidence on the use COVID-19 vaccines in patients with diabetes mellitus. METHODS: We performed a thorough literature search with regard to COVID-19 vaccines in patients with type 1 and type 2 d
BACKGROUND AND AIMS: To summarize the available evidence on the use COVID-19 vaccines in patients with diabetes mellitus. METH …
Immunogenicity and safety of hepatitis B vaccination in patients with type 2 diabetes in China: An open-label randomized controlled trial.
Han B, Liu W, Du J, Liu H, Zhao T, Yang S, Wang S, Zhang S, Liu B, Liu Y, Cui F. Han B, et al. Vaccine. 2021 Jun 8;39(25):3365-3371. doi: 10.1016/j.vaccine.2021.04.058. Epub 2021 May 13. Vaccine. 2021. PMID: 33992438 Clinical Trial.
OBJECTIVE: Hepatitis B virus (HBV) infection remains a global public health challenge. ...The immunogenicity and safety of two major hepatitis B vaccines were evaluated in Chinese patients with diabetes. ...
OBJECTIVE: Hepatitis B virus (HBV) infection remains a global public health challenge. ...The immunogenicity and safety of two …
miR-223: infection, inflammation and cancer.
Haneklaus M, Gerlic M, O'Neill LA, Masters SL. Haneklaus M, et al. J Intern Med. 2013 Sep;274(3):215-26. doi: 10.1111/joim.12099. Epub 2013 Jun 25. J Intern Med. 2013. PMID: 23772809 Free PMC article. Review.
Expression of the microRNA miR-223 is deregulated during influenza or hepatitis B infection and in inflammatory bowel disease, type 2 diabetes, leukaemia and lymphoma. ...Validated targets for miR-223 that have effects on inflammation and infect …
Expression of the microRNA miR-223 is deregulated during influenza or hepatitis B infection and in inflammatory bowel disease, …
Dual Infection with Hepatitis B Virus and Hepatitis C Virus Correlated with Type 2 Diabetes Mellitus.
Lin PY, Chen SC, Lo TC, Kuo HW. Lin PY, et al. Exp Clin Endocrinol Diabetes. 2020 Jan;128(1):38-42. doi: 10.1055/a-0794-6135. Epub 2019 Jan 17. Exp Clin Endocrinol Diabetes. 2020. PMID: 30654388 Clinical Trial.
BACKGROUND: Conflicting data exist regarding the relationship between dual infection of hepatitis B virus (HBV) and hepatitis C virus (HCV) with type 2 diabetes mellitus (T2DM). ...METHODS: A total of 9621 participants in a communi …
BACKGROUND: Conflicting data exist regarding the relationship between dual infection of hepatitis B virus (HBV) and hepatit
Hepatic steatosis and development of type 2 diabetes: Impact of chronic hepatitis B and viral specific factors.
Yu MW, Lin CL, Liu CJ, Huang YW, Hu JT, Wu WJ, Wu CF. Yu MW, et al. J Formos Med Assoc. 2021 Nov 8:S0929-6646(21)00486-1. doi: 10.1016/j.jfma.2021.10.014. Online ahead of print. J Formos Med Assoc. 2021. PMID: 34764005 Free article.
BACKGROUND: Chronic hepatitis B (CHB) was associated with a lower prevalence of nonalcoholic fatty liver disease (NAFLD). The impact of CHB on the link between NAFLD and type 2 diabetes (T2D) and related virological implications remain unclear. …
BACKGROUND: Chronic hepatitis B (CHB) was associated with a lower prevalence of nonalcoholic fatty liver disease (NAFLD). The …
Periodontal Regenerative Therapy in Patient with Chronic Periodontitis and Type 2 Diabetes Mellitus: A Case Report.
Seshima F, Nishina M, Namba T, Saito A. Seshima F, et al. Bull Tokyo Dent Coll. 2016;57(2):97-104. doi: 10.2209/tdcpublication.2015-0041. Bull Tokyo Dent Coll. 2016. PMID: 27320299 Free article.
We report a case of generalized chronic periodontitis and type 2 diabetes mellitus requiring periodontal treatment including regenerative therapy. The patient was a 66-year-old man who presented with the chief complaint of gingival inflammation and mob …
We report a case of generalized chronic periodontitis and type 2 diabetes mellitus requiring periodontal treatme …
[Study on the risk of hepatitis B-related cirrhosis combined with type 2 diabetes mellitus for the occurrence of primary hepatocellular carcinoma].
Zhang LL, Li YF, Zhang C, Wu XF, Ma Y, Li L. Zhang LL, et al. Zhonghua Gan Zang Bing Za Zhi. 2019 Oct 20;27(10):788-792. doi: 10.3760/cma.j.issn.1007-3418.2019.10.010. Zhonghua Gan Zang Bing Za Zhi. 2019. PMID: 31734994 Chinese.
Objective: To investigate whether type 2 diabetes mellitus increases the risk of hepatitis B-related cirrhosis combined with type 2 diabetes mellitus for the occurrence of primary hepatocellular carcinoma, and …
Objective: To investigate whether type 2 diabetes mellitus increases the risk of hepatitis B-relat …
Prevalence of hepatitis B and hepatitis C among diabetes mellitus type 2 individuals.
Villar LM, Geloneze B, Vasques ACJ, Pires MLE, Miguel JC, da Silva EF, Marques VA, Scalioni LP, Lampe E. Villar LM, et al. PLoS One. 2019 Feb 28;14(2):e0211193. doi: 10.1371/journal.pone.0211193. eCollection 2019. PLoS One. 2019. PMID: 30817756 Free PMC article.
Diabetes mellitus type 2 (DM2) patients have higher risk to be infected with parenterally transmitted viruses, like hepatitis B or C virus. ...Six individuals (1.1%) were isolated anti-HBc, 37 (6.9%) had HBV infection resolved (anti-HBc+/
Diabetes mellitus type 2 (DM2) patients have higher risk to be infected with parenterally transmitted viruses, l
Multifocal lipoatrophy secondary to insulin injection in a patient with type 2 diabetes, hepatitis B virus infection, and liver cirrhosis.
Wu Y, Lou X. Wu Y, et al. J Int Med Res. 2021 Mar;49(3):300060521990237. doi: 10.1177/0300060521990237. J Int Med Res. 2021. PMID: 33682487 Free PMC article.
We report the case of a 69-year-old non-obese female patient with type 2 diabetes mellitus, decompensated liver cirrhosis, and hepatitis B virus (HBV) infection who developed multifocal lipoatrophy during the administration of human insul …
We report the case of a 69-year-old non-obese female patient with type 2 diabetes mellitus, decompensated liver …
307 results